Faringosept - a drug used in diseases of the oral cavity.
Structure and Composition
The drug release
in the form of compressed lozenges 10 mg. One lozenge contains active component - ambazone 10 mg.
The blister packs of 20 lozenges.
The analogue Faringosept of the active substance is ambazone.
Pharmacological action Faringosept
According to the instructions Faringosept used for the treatment of oral diseases caused by pneumococci, staphylococci and streptococci. In the opinion of Faringosept bacteriostatic.
Application Faringosept effective as monotherapy for the treatment of various diseases of the oral cavity and oropharynx mild. The drug or analog Faringosept acts locally to prevent the development of resistance of pathogens to antibiotics.
Absorption of the drug increases salivation, resulting in reduced manifestations of diseases such as sore throat, reducing discomfort in swallowing. Thanks to the local action of the drug did not inhibit the growth of the natural intestinal flora, therefore, exclude the development of dysbiosis.
The optimum content of active substance in the saliva reached after three days after the application Faringosept.
According to the instructions Faringosept indicated for the treatment of diseases of the oropharynx and oral cavity, caused by sensitive pathogens. These include:
- sore throat;
Also, the drug and analogue Faringosept used to prevent complications after surgery (tooth extraction, or tonsillectomy).
Dosing and dosing regimen Faringosept
Children over seven years and adults prescribed the following regimen: one candy from three to five times a day. Lozenges must be resolved. In the opinion of Faringosept be applied after some time (15 minutes) after meals. After receiving the candy should not eat and drink for two hours. Duration of treatment is at least five days. Perhaps longer treatment by the physician.
Children from three to seven years, usually administered in the following dosage Faringosept 30 mg per day divided into three doses.
Increased dosages recommended not lead to increased therapeutic effect.
According to the instructions
Faringosept contraindicated in children aged up to three years, as well as hypersensitivity to ambazone.
Side effects Faringosept
In the opinion of Faringosept well tolerated by patients. Slight hypersensitivity reactions, facial flushing, itching, rash, urticaria, angioedema.
Use during pregnancy and breast-feeding
Clinical data on the use of ambazone during pregnancy and breastfeeding is not available.
Taking the drug or analogue Faringosept during pregnancy is possible in the case of the ratio of benefits and risks for the mother and the fetus.
Since Faringosept contains lactose and sucrose should be avoided receiving people with fructose or galactose intolerance, the lack of sucrase-isomaltase, malabsorption syndrome, or glucose-galactose shortage Lapp lactase. Also, caution should be used drug in patients with diabetes mellitus.